Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial
Williams JG., Alam MF., Alrubaiy L., Arnott I., Clement C., Cohen D., Gordon JN., Hawthorne AB., Hilton M., Hutchings HA., Jawhari AU., Longo M., Mansfield J., Morgan JM., Rapport F., Seagrove AC., Sebastian S., Shaw I., Travis SPL., Watkins A.